Clinical Trial Update: ERG/5-HTP in Fragile X Syndrome (FXS) [Phase 2]

View source ↗

Summary

Phase 2 trial update for ERG/5-HTP in Fragile X Syndrome reports completed results with findings posted on 2024-09-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fragile Syndrome

Drugs mentioned

• 5-HTP (5-hydroxytryptophan)
• ERG

Snippet

Sponsor: Elizabeth Berry-Kravis | Conditions: Fragile X Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2024-09-19